Beyond glioblastoma, the authors observed that RBBP4 knockdown significantly reduced cyclin D1 expression in hepatocellular carcinoma, colorectal cancer, and breast cancer cell lines (data not shown), further supporting the importance of RBBP4 in regulating gene expression across various tumors. This evidence concerns the gene CCND1 and breast carcinoma.